Aurobindo Pharma to sell Cuddalore unit - MarketLine Financial Deals

Aurobindo Pharma to sell Cuddalore unit

Aurobindo Pharma to sell Cuddalore unit - MarketLine Financial Deals
Aurobindo Pharma to sell Cuddalore unit
Published May 31, 2012
2 pages — Published May 31, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Aurobindo Pharma, Ltd., an India-based pharmaceutical company manufacturing active pharmaceutical ingredients (APIs), intermediates and generic formulations, has agreed to sell its unit in Cuddalore, India.

  
Source:
Document ID
MA111553_120605
Country
Ticker
524804=IN
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Aurobindo Pharma to sell Cuddalore unit" May 31, 2012. Alacra Store. Dec 11, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Aurobindo-Pharma-to-sell-Cuddalore-unit-2052-82514>
  
APA:
MarketLine Financial Deals. (2012). Aurobindo Pharma to sell Cuddalore unit May 31, 2012. New York, NY: Alacra Store. Retrieved Dec 11, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Aurobindo-Pharma-to-sell-Cuddalore-unit-2052-82514>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.